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Abstract: There is strong support for the role of the endocannabinoid system and the noncannabinoid 
lipid signaling m olecules, N -acylethanolam ines (N A Es), in  cocaine reward and w ithdraw al. In the 
latest study, w e investigated the changes in the levels o f the above m olecules and expression of 
cannabinoid receptors (CB1 and CB2) in several brain regions during cocaine-induced reinstatem ent 
in rats. By u sing intravenous cocaine self-adm inistration and extinction procedures linked w ith  
yoked triad controls, w e found that a prim ing dose of cocaine (10 m g /k g , i.p.) evoked an increase 
of the anadam ide (A EA ) level in the hippocam pus and prefrontal cortex only in  anim als that had 
previously self-administered cocaine. In the same animals, the level of 2-arachidonoylglycerol (2-AG) 
increased in the hippocam pus and nucleus accumbens. Moreover, the drug-induced relapse resulted 
in a potent increase in NAEs levels in the cortical areas and striatum  and, at the same tim e, a decrease 
in the tissue levels of oleoylethanolam ide (O EA ) and palm itoylethanolam ide (PEA ) w as noted in 
the nucleus accum bens, cerebellum , a n d /o r  hippocam pus. A t the level of cannabinoid receptors, 
a prim ing dose of cocaine evoked either upregulation of the CB1 and CB2 receptors in the prefrontal 
cortex and lateral septal nuclei or dow nregulation of the C B1 receptors in  the ventral tegm ental 
area. In  the m edial globus pallidus w e observed the upregulation of the C B2 receptor only after 
yoked chronic cocaine treatm ent. O ur findings support that in the rat brain , the endocannabinoid  
system and N AEs are involved in cocaine induced-reinstatem ent where these m olecules changed in a 
region-specific m anner and m ay represent brain  m olecular signatures for the developm ent of new  
treatm ents for cocaine addiction.
Keyw ords: cocaine reinstatement; cannabinoid receptors; endocannabinoids; im m unohistochem istry; 
L C -M S/M S m ethod; N -acylethanolam ines; relapse
1. Introduction
Cocaine use disorder continues to rem ain a major world health issue. According to the European 
M onitoring  C entre for D rugs and D rug A ddiction (EM C D D A ) cocaine is the m ost com m only used 
illegal stim ulant used in Europe [1] and a relapse in taking it belongs to the m ore difficult challenges 
undertaken during the treatm ent for both the patient and the physician. Moreover, the pathophysiology 
of this brain disorder still rem ains unclear.
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In  recent years, the changes in the lipid signaling m olecules such as endocannabinoids 
and N -acetylethyloam ines (N A Es) in cocaine rew ard and the dru g's w ithdraw al have been 
dem onstrated [2- 6]. In  fact, self-adm inistration of cocaine induced both a potent decrease of the 
anandam ide (A EA ) levels in  the cerebellum  and in the 2-arachidonoylglycerol (2-A G ) levels in  the 
hippocam pus and striatum  w ith few er cannabinoid CB1 receptors, w hile increased 2-AG levels w ere 
observed in the frontal cortex and cerebellum  and w ere w as linked w ith  cocaine reward in rats [2,7]. 
A  cocaine-free period w ith  extinction training resulted in a potent reduction of the endocannabinoid 
levels in the limbic and subcortical areas w ith the cannabinoid CB2 receptor downregulation [7].
A part from  endocannabinoids, w hich  are d irect agonists of C B  receptors, there are also other 
lipid-based m ediators— N AEs (oleoylethanolam ide (OEA) and palm itoylethanolam ide (PEA))— and 
they act indirectly on the cannabinoid receptors. N A Es are the endogenous ligands of the nuclear 
receptor peroxisom e proliferator-activated receptors (PPA R -a) and the transient receptor potential 
cation channel subfam ily V  mem ber 1 (TRPV1) [8 ]. PEA and OEA levels could strengthen the effect of 
A EA  on the cannabinoid receptor or TRPV1 ("en tou rag e effect") [9 ] and consequently  potentiate 
the effect of endocannabinoids [10]. C ontingent cocaine adm inistration upregulated the N A Es 
(oleoylethanolamide (OEA) and palm itoylethanolam ide (PEA)) levels in the limbic areas [2], w hile the 
levels of these m olecules w ere also seen to increase during extinction in the prefrontal cortex and the 
hippocam pus only during the rats' self-adm inistered cocaine phase [2,7].
In  behavioral preclinical studies, the evidence for engagem ent of the endocannabinoid  system  
on drug-seeking behavior w as dem onstrated using specific CB1 receptor antagonists that attenuated 
cocaine-prim ed and cue-induced reinstatem ent of cocaine-seeking behavior in rats [11- 13].
To further exam ine the involvem ent of endocannabinoids and N A Es in cocaine addiction, this 
study attem pted to reveal the role of A EA , 2-A G , O EA , and PEA  in cocaine relapse. Through using 
the drug-prim ed procedure w ith  a yoked triad control w ith  rats, w e studied the m olecule tissue 
levels w ith  using liquid chrom atography w ith  a tandem  m ass spectrom etry (L C -M S /M S) m ethod. 
Finally, w e exam ined the cannabinoid CB1 and C B2 receptor brain  expression follow ing cocaine 
reinstatem ent. W e selected several rat brain  structures related to substance use disorders including 
prefrontal cortex (executive control), am ygdala and hippocam pus (m em ory and learning), dorsal 
striatum  (habit form ing learning), nucleus accum bens (rew ard processing), ventral tegm ental area 
(rew ard-related and goal-directed behaviors), and cerebellum  (nonm otor function, intertw ined w ith 
brain reward, m otivational drive, saliency, inhibitory control, and insight processes) [14- 16].
The present study on the role of the endocannabinoid  system  in  the cocaine dependence 
m echanism  m ay contribute to the m any m issing questions about cocaine's interaction of the 
endocannabinoid  system , and m ay help to determ ine w hether the endocannabinoid  system  is the 
target point for new  addiction treatm ent drugs in the future.
2. Results
2.1. Behavioral Studies
A fter 14 self-adm inistration sessions, the anim als show ed stable lever-pressing rates during the 
last 3 self-adm inistration days with less than a 10% difference in their daily intake of cocaine (Figure 1). 
The m ean num ber of cocaine infusions per day during the last 3 self-adm inistration days varied from 
26 to 29 w hile during 14 experim ental sessions the anim als received 164.9 ±  9.2 m g /ra t of cocaine.
Figure 1 show s the behavioral responses of the rats that underw ent cocaine self-adm inistration, 
extinction training, and cocaine-induced reinstatem ent of seeking behavior. A  tw o-w ay AN OVA 
for repeated m easures for anim als previously  self-adm inistered cocaine for tissue level of 
endocannabinoids and N A Es and expression of cannabinoid  receptor experim ents show ing the 
significant effect of lever x session interaction (F(24,336) =  10.72; p  <  0.001 and F(24,336) =  9.47; 
p  <  0.001, respectively). The post hoc analyses revealed a greater frequency of presses on the "activ e" 
lever than on the "in activ e" lever from  the 1st or 2nd cocaine self-adm inistration session till the 1st
or 2nd extinction day. D uring extinction training, neither drug nor drug-paired stim uli werte given 
in response to lever pressing, resulting; in a gredual deerease in "a c tiv e" lever peesses (p <  0.001). 
M oreover, an intraprritoneal injection of cocaine induced a significant increase of "active" lever presses 
during the rem statem ent of drug;; seeking ire rats that previously self-adm m istered cocaine (p <  0.01). 
The re w as no alteration in inactive lever p resses aftee expos ure to prim  ing.
In  the yoked cocaine and yoked saline gruups, the difference betw een pressing the; "a c tiv e" 
versus the "in activ e" lever failed to rerch  significance both in the experim ent used to evaluate the 
endocannabinoid  and N A Es tissue level and in the expression of cannabinoid receptors (a tw o-w ay 
ANOVA for repeated measuree; Yoked cocaine + i.p. cocoine: F(24,336) =  0.83; p =  0.69 and F(24,288) =  1.27; 
p  =  0.18; Yoked salm e + i.p. cocaino: F(24,336) =  0.d9; p =  0.79 find F(24,288) =  0.31; p  =  0.99; Yoked 
saline + i.p. saline: F(24,336) =  0.45; p  =  0.83 and F(24,288) =  0.31; p  =  0.99, respectively).
Figure 1. The number (mean ±  SEM) of active (black bars) and inactive (white bars) lever presses 
during the last three self-adm inistration (SA) and extinction (EXT) sessions in rats trained to 
self-administered cocaine ,0.5 m g/kg/in fu sion ) and forced to cocaine priming (COC 10 m g /k g  i.p.) 
during. the reinstatement test in active cocaine e Lp. cocaine, yoked cocaine + i.p. cocame, yoked 
safine + i.p. cocaine and yoked saline + i.p. saline was shown. Panel A— experiment to evaluate 
the endocannabinoid and NAEs tissue level; panel B— experiment to evaluate the expression of 
cannabinoid receptors. N = 7-8 rats/group. *** p <  0.001 vs. active lever SA; ## p <  0.01 vs. active lever 
EXT, (Newm an-Kelus test).
2.2. Tissue Level o f  Endocannabinoid and N AEs in Rat Brain Structures
In  the yoked saline + i.p. saline group, the A EA  levels ranged from  11.37 to 16.33 n g /g , w ith 
the h ighest concentration observed in  the nucleus accum bens and the low est in  the frontal cortex. 
As show n in Figure t ,  reinstatem ent of seeking behavior in the anim als w hich had undergone a peior 
procedure of cocaine eelf-adm inistration resulted in a changes in the AEA levels in all of the analyzed 
brain  structures: the cerebellum  (F(3,30) =  h2.52; p <  0.001), nucleus accum bens (F(3,28) =  23.41; 
p  <  0 .00r ), h ippocam pus (Ft3,30) =  6.43; p  <  0.01S, dorsal striatum  (F(3,29) =  4.88; p  <  0.05), frontal 
cortex (F(3,28) =  6.70; p <  0.05), and prefrontal cortex (F(3,28) =  12.46; p <  0.001). A  signiftcant 
decrease in the; A EA  ievel w a t observed in the cerebellum  and nucleua accum bens in  the anim als 
w hich self-adm inistered (at lraet p  =  0.01) or passively  received (p <  0 .00 t) cocaine in com parison to 
the yoked saline anim als. Instead, in the h>refrontal cortex (p <  0.01) and hippocam pus (p <  0.05) an 
increase was teparted only in cocaine self-administered rats. Moreover, the animals that had previously 
self-adm inistered cocaine show ed a  reduction of the A EA  level in the dorsal striatum  and. frontal 
cortex w hen com pared 0o the yoked saline + i.p. cocaina and yoked cocaine + i.p. cocaine rats which, 
during restatem ent of seeking-behavior, received an intraperitoneal injection of cocaine (10 m g /k g ).
Figure 2. Levels os anadamide (AEA) in brain structures in rats previously self-administered cocaine 
(14 days) (Active cocaine) or which passively received cocaine (Yoked cocaine) or saline (Yoked saline;) 
and underwent extinction training (s0 days) and drug-induced reinstatement (10 m g /k g  cocaine i.p. 
or saline i.o.)- N = 7 -8  rats/group. A/ll dota are expressed as ihe meanv ±  SEM. * p <  0.05, ** p < 0.01, 
p < 0.00 1 vs. Yoked s aline i  saline i.p.; ~ p <  0.05 , “  p < 0.01 , p <  0.00 1 vs . Yoked saline + coiaine i.p .;
# o < 0.05,## p < 0 .01 ,### p <  0.001 vs . Yoked cocaine + cocaine i.p. PFC—prefrontal cortex; FC—frontal 
cortex, HIP— hippocampus, STR— dorsal striatum, NAC— nucleus accumbens, CER— cerebellum.
teT;hebeec..o nec,entration of 2-A G  in the control (yoked saline +  i.p. saline) group ranged from  3.21 
to 5.12 p g /g , w ith  the highest concentration in the dorsal striatum  and the low est in  the nucleus 
accum bens. C ocaine-induced reinstatem ent influenced the 2-A G  levels in the follow ing structures: 
tho erontal cortex (0(3,28) =  11.27; p <  0.001), hippocam pus (F(3.29) =  33.38; p <  0.001), dorsal striatum  
(F(3,30) =  20.22; p <  0.001), nudeus accem bens (F(a,29) =  3 .6 2  p <  0.05), and cerebellum  (F(3,t8) =  6.23; 
p  <  0.01), but not in the prefrontal cortex (F(3,29) =  2.74). The post hoc analyses revealed a significant 
decrease in the 2-A G  level in the frontal cortex (p <  0.001) and cerebellum  (p <  0.05), w hilst in the 
hippocam pus (p <  0.001) and in  the nucleus accum bens (p <  0.05), an  increase w as reported in  rats 
that had self-adm inistered cocaine in com parison to the corresponding yoked saline +  i.p. saline 
group. In the anim als passively adm inistered cocaine, a significant enhancem ent in the 2-AG level in 
the dorsal striatum  (p <  0.001) and a significant reduction in the cerebellum  (p <  0.05) w as observed 
(Figure 3).
Figure 3. Levels of 2-arachidonoylglycerol (2-AG) in brain structures in rats previously 
self-administered cocaine (14 days) (Active cocaine) or which passively received cocaine (Yoked cocaine) 
or saline (Yoked saline) and underwent extinction training (10 days) and drug-induced reinstatement 
(10 m g/kg  cocaine i.p. or saline i.p.). N = 7-8 rats/group. All data are expressed as the means ±  SEM.
* 0 <  0.05, ** p <  0.01, *** p <  0.001 vs . 'Yoked saline + saline i.p.; e p <  0.05, “  p <  0 .01, p <  0.001 
vs. Yoked saline + cocaine i.p.; # p <  0.05, ## p <  0.01, ### p <  0.001 vs. Yoked cocaine + cocaine i.p.
A description of the abbreviations has been placed under Figure 2.
In  the yoked saline + i.p. saline group, the O EA  levels ranged from  21.78 to 58.78 n g /g , w ith  
the h ighest concentration in  the nucleus accum bens and the low est in the prefrontal cortex. Cocaine 
treatm ent during; reinstatem ent of seeking behavior resulted in a change in  the O EA  level in the all 
studied struct<res: ihe prefr<ntal cortex (F(3,30) =  24.36; p <  0.001), frontal cortex (F(3,30) =  3.82; 
p <  0.05), hippocam pus (F(3,30) =  29.15; p <  0.001), dorsal striatum  (F(3,29) =  53.84; p <  0.001), nucleus 
accum bens (F(3,30) =  69.02; p  <  0.001 ), and cerebellum  (F(3,29) =  20.80; p  <  0.001). In the rats that had 
self-adm inistered cocaine and thore given yoked cocaine; injections;, a significant increase in the OEA 
levels w as observed in ihe prefrontal cortex (p <  0.001) 2 nd dorsal striatum  (p <  0.001) w hen compared 
to the yoked saline -1- i.p. saline r<ts. On the other hand, both groups previously rdm inisterid  cocaine, 
actively  or pass<eely, dem onstrated a significant reduction of the level of O EA  in the hippocam pus 
(p <  0.001) and cerebellum  (p <  0.001). M oreover, the an im (ls  previously self-adm inistere9  cocaine 
displayed a reduction of the O EA  level in  the nucleus accum bans (p <  0 .005) in  com parison to all of 
the yoked groups. The D unnett's Mulfip<e C om p irison  test alse revealed a significent decrease af .he 
(OEA level in the h ippocam pus of the rats w hich  had prev;ously received saline and w ere exposed 
to noncontingent reinforcem ents (je <  0.001) w hen com pare< to the corresponding yoked sxline + i.p. 
saline group (Figure 4).
"The concentsation of PEA ranged from 30.90 to 83.60 n g /g  in the control (yoked saline + i.p. saline) 
group, with the highest concentration in the nucleus accum bens and the lowest in the prefrontal cortex. 
Cocaine administration induced changes in the PEA levels in all of the structures (the prefrontal cortex 
(F(3,30) =  231.20; p  <  0.001), frontal cortex (F(3,30) =  59.06; p  <  0.001), h ippocam pus (F(3,29) =  6.59; 
p  <  0.001), dorsal striatum  (F(3,29) =  68.15; p  <  0.001), nucleus accum bens (F(3,30) =  75.41; p  <  0.001), 
and cerebellum  (F(3,29) =  81.28; p  <  0.001)). D uring cocaine-induced reinstatem ent in rats previously 
self-administered cocaine, an increase in the PEA levels was observed in the prefrontal cortex (p <  0.001), 
the hippocam pus (p <  0.05), and dorsal striatum  (p <  0.001), w hile a decrease w as noted in the nucleus 
accum bens (p <  0.001) and cerebellum  (p <  0.001). In rats passively  adm inistered cocaine, increases 
in the PEA  levels in the frontal cortex (p <  0.001) and dorsal striatum  (p <  0.001) and decreases in the 
cerebellum  (p <  0.001) w ere reported (Figure 5 ).
Figure 4. Levels of oleoylethanolamide (OEA) in brain structures in rats previously self-administered 
cocaine (14 days) (Active cocaine) or which passively received cocaine (Yoked cocaine) or saline (Yoked 
saline) and underwent extinction training (10 days) and drug-induced reinstatement (10 m g/kg cocaine
i.p. or saline i.p.). N = 7-8 rats/group. All data are expressed as the means ±  SEM. * p <  0.05, ** p <  0.01, 
*** p <  0.001 vs. Yoked saline + saline i.p .;" p <  0.05, “  p <  0 . 0 1 , p < 0.001 vs. Yoked saline + cocaine i.p.; 
# p <  0.05,## p <  0.01, ### p <  0.001 vs. Yoked cocaine + cocaine i.p. A description of the abbreviations 
has been placed under Figure 2.
Figure 5. Levels of palmitoylethanolamide (PEA) in brain structures in rats previously 
self-administered cocaine (14 days) (Active cocaine) or whichpassively received cocaine (Yokedcocaine) 
or saline (Yoked saline) and underwent extinction training (10 days) and drug-induced reinsCatement 
(10 m g/kg  cocaine i.p. or saline i.p.). N = 7-8 rats/group. .All data are expretsed as the means ±  SEM.
* p <  0.05, ** p <  0.01, *** p a  0.001 vs. Yoked saltne + saline i.p.; " p <  0.05, “  p <  0.01, p <  0.001 
vs. Yoked saline + cocaine i.p.; # p <  0.05, ## p <  0.01, ### p <  0.001 vs. Yoked cocaine + cocaine i.p.
A description of the abbreviations has been placed under Figure 2.
2.3. Expression o f  the CB1 and CB2 Receptor Protein
In  the cocaine-induced reinstatem ent phase, w e observed a decrease in the expression of CB1 
receptor protein in the ventral tegm ental area (F(3,24) =  -4.95; p <  0.01) m  boih  of the rtudied groups 
and in the control group w ith a  cocaine i.p. dose. Furtherm ore, significant changes w ere observed in
the lateral septal nuclei (F(3,24) =  8.54; p  <  0.001) and prefrontal cortex (F(2,14) =  8.46; p  <  0.01), and 
an increase of the expression of CB1 receptors w as observed in the group of rats that had actively 
self-adm inistered cocaine (at least p  <  0.05). Interestingly, significant changes w ere dem onstrated in 
the dorsal striatum  (F(3,24) =  4.93; p <  0.05), and a decrease in the CB1 receptors level w as observed in 
the yoked cocaine + i.p. cocaine group. A  one-w ay AN OVA did not show  changes in CB1 receptor 
expression in  the basolateral and basom edial am ygdala (F(3,24) =  1.06), nucleus accum bens core 
(F(3,24) =  2.43) and shell (F(3,24) =  0.46), m edial globus pallidus (F(3,24) =  1.69), hippocam pus 
(F(3,24) =  1.23), and substantia nigra (F(3,24) =  2.72). The results of the analysis are shown in Figure 6 
(top panel).
Figure 6. Results of immunohistochemistry analysis of membrane's cannabinoid receptor 1 and 2 in the 
reinstatement cocaine phaoe. All data are expressed as the meane ±  SEM. IN = 1 rats/group. *p  < 0.05,
** p < 0.01, *** p < 0.001 vs. Yoked saline + seline i.p.; “  p < 0.01 vs. Yoked saline + cocainc i.p.; # p < 0.05,
## p < 0.01 m# p < 0.001 vs. Yoked cocaine + cocaine i.p. PFC—prefrontal cortex; HIP -  hippocampus,
BLA—basolateral and basomedial amygdala, NAC core or shell—nucleus accnmbens core ob shell,
LSN—lateral septal nuclei, STR—dorsal striatum, MGP—medial globus pallidus SN—substantia nigra,
VTA—ventral tegmental area.
In  the CB2 receptor expression, w e noticed statistically  significant changes in the lateral septal 
nuclei (F(3,24) =  9.85; p  <  0.001), and the p ost hoc tests dem onstrated an  increase in the receptor 
level in chronic and acute cocaine-treated rats (p <  0.001). M oreover, significant changes w ere noted 
in the prefrontal cortex (F(3,24) =  11.39; p  <  0.001), and an increase in  the receptors w as noticed in 
active cocaine self-adm inistered (p <  0.001) and yoked saline + i.p. cocaine (p <  0.05) anim als exposed 
to cocaine intraperitoneal in jection during reinstatem ent. Furtherm ore, significant changes w ere 
demonstrated in medial globus pallidus (F(3,24) =  6.53; p <  0.01), w hile an increase w as observed only 
in yoked cocaine + i.p. cocaine rats (p <  0.01). Also in the dorsal striatum  a sign ifkant changes in the- 
CB2 receptor expression w ere indicated (one-w ay ANOVA (F(3,24) =  3.57; p  <  0.05); a decrease in the
receptors level in the passive cocaine group w as noted in com parison to the other experimental groups. 
In the nucleus accumbens core (F(3,24) =  1.14), nucleus accumbens shell (F(3,24) =  0.29), basolateral and 
basom edial amygdala (F(3,24) =  0.80), the substantia nigra (F(3,24) =  2.58), hippocampus (F(3,24) =  1.60), 
and ventral tegm ental area (F(3,24) =  1.77), the level of CB2 receptors w as unchanged. The results of 
analysis are show n in Figure 6 (bottom panel).
Table 1 shows the observed changes in tissue levels of eCS and NAEs and changes in the expression 
of cannabinoid receptors (CB1 and CB2) in the rat brain structures.
Table 1. Changes in the endocannabinoid, NAE (tissue levels), and cannabinoid receptors (CB1 and 
CB2) in the selected rat brain structures during cocaine-induced reinstatement.
Brain A E A 2-AG O E A P EA CB1 CB2
Structure A Y  Y S A Y Y S  A Y Y S A Y  Y S A Y Y S  A Y Y S
PFC f -- f f -- f -- -- f -- -- f -- f
FC -- -- -- I -- -- -- f -- -- f  --
HIP f -- -- f -- -- I I I f
BLA n /a
NAC core
- I I  -- f -- I I
NAC shell
LSN n /a f -- -- f f f





VTA I I I  -- -- --
CER I I  -- I I -- I I -- I I  -- n /a
A—active cocaine + i.p. cocaine group, Y—yoked cocaine + i.p. cocaine group; YS—yoked saline + i.p. cocaine.
PFC—prefrontal cortex; FC—frontal cortex, HIP—hippocampus, BLA—basolateral amygdala, NAC core and 
shell—nucleus accumbens core and shell, LSN—lateral septal nuclei, STR—dorsal striatum, MGP—medial globus
pallidus, SN—substantia nigra, VTA—ventral tegmental area, CER—cerebellum. f —increase, I —decrease, no
changed, n/a—not analyzed.
3. Discussion
The present study demonstrates the alterations in the level of endocannabinoids and cannabinoid 
CB1 and CB2 receptors in the rat brain structures following a cocaine-induced relapse. At the same time, 
w e also found cocaine-induced changes in O EA  and PEA  concentrations after the cocaine challenge 
dose in the anim als w ith  a previous m otivational and experim ental delivery of cocaine. This paper 
follows our previous study where w e reported several changes in the concentration of AEA and 2-AG 
as w ell as O EA and PEA linked to cocaine reward or to cocaine w ithdraw al [2].
In the current study, a cocaine prim ing dose resulted in a significant increase of the AEA level in 
the hippocampus and prefrontal cortex only in animals with a previous motivational intake of cocaine. 
Since the changes w ere not present in yoked saline +  i.p. cocaine or cocaine +  i.p. cocaine controls 
(present study), during cocaine self-adm inistration and in the cocaine-free period w ith  extinction 
training [2], it m eans the specific effect of a cocaine-induced relapse is attributed to the lim bic A EA  
levels. The reductions of the AEA levels in the frontal cortex and striatum  linked to previous cocaine 
self-adm inistration and in the nucleus accum bens and cerebellum  due to repeated cocaine injections 
did not reflect cocaine-induced reinstatem ent but, instead, rather persistent adaptations after chronic 
cocaine exposure [2].
W ith regards to the second endocannabinoid  studied, the 2-A G  levels also increased in 
the hippocam pus and nucleus accum bens w hile they decreased in the frontal cortex only after 
cocaine prim ing in rats previously  self-adm inistered cocaine. The recent literature data confirm s 
the involvem ent o f the endocannabinoid  m olecules (especially  2-A G ) in  the hippocam pus in the 
(i) m odulation of the dopam inergic system  [17,18] and in (ii) cocaine-induced reinstatem ent [19].
In  fact, w e reported that system ic injections w ith blockers of fatty acid am ide hydrolase (FAA H ), the 
main enzyme responsible for terminating the actions of the endocannabinoid anandamide, was able to 
reduce a cocaine-primed relapse in rats [20] . The protective effects of FAAH inhibitions were also noted 
for cocaine seizures and cell death in the hippocampus in a model of the drug's intoxication in mice [21]. 
Furtherm ore, previous research on the endocannabinoids and stress responses indicated a significant 
role of 2-A G  in regulating stress behaviors [22]. In  chronic stress, the 2-A G  level increased [23], and 
the rise in the striatal 2-AG level in may indicate adaptation to a stressful situation in the rats that had 
had a passive cocaine intake.
Parallel im m unohistochem ical analyses revealed that cocaine priming enhanced the expression of 
the CB1 and CB2 receptors in  the prefrontal cortex and lateral septal nuclei. The upregulation of the 
CB1 receptors observed in the prefrontal cortex and the lateral septal nuclei was present during cocaine 
self-adm inistering rats and should be linked to the drug rewarding properties [7]. The lateral septum is 
the middle of the relay for connections from the CA3 hippocampus to the ventral tegm ental area, w hich 
m akes it possible to link the reward signals w ith  the context in w hich  they occur [4 ]. A n increase in 
the expression of CB1 and CB2 receptors observed in the lateral septal nuclei m ay also be the result of 
conditional stim uli accom panying the experim ent (sound and light signal associated w ith the dose of 
the drug) [24]. The present neurochemical data supports our previous behavioral findings in which we 
reported that tonic activation of CB1 is involved in cocaine-induced reinstatem ent of cocaine-seeking 
behavior [20]. Interestingly, w e also observed a decrease in the CB1 receptor expression in the ventral 
tegm ental area seen in all of the studied rat groups, including the anim als treated w ith acute cocaine. 
Reduced levels of CB1 receptors in the ventral tegm ental area in all of the experimental groups suggest 
a pharmacological effect of cocaine-priming. In the ventral tegm ental area, CB1 receptors are expressed 
on G A BA  neurons and their reduction observed in this paper suggests a pharm acological effect 
of cocaine-prim ing leading to the rise of the dopam ine level and increased sensitivity to the drug 
effects [3,25,26]. Upregulation of the CB2 receptors seems to be related to the last cocaine dose, because 
an increase in the CB2 receptor expression w as also presented in the control group w ith  a single i.p. 
cocaine dose.
The levels of endocannabinoids reflect their concentration at the tim e of tissue collection for 
analysis (the neurotransm itter presence in the synaptic space and in presynaptic neurons), w hich may 
not necessarily correlate w ith  the expression of cannabinoid receptors. Sim ilar results w ere reported 
during chronic stress, w here the 2-A G level w as increased [23], w hile the expression of CB1 receptor 
did not change in any brain regions [27].
Recently, Luchicchi et al. (2010) dem onstrated that N A Es play a role in behavioral and 
neurochem ical effects related to cocaine addiction [28]. The finding from  this study show ed that 
N A Es are involved in the relapse o f cocaine-seeking behavior. O EA  and PEA  are endogenous lipid 
transm itters w ith  sim ilar properties to A EA  and 2-A G , although they did not act on cannabinoid 
receptors. They act through the nuclear proliferator-activated receptor alpha (PPA R a), the transient 
receptor potential vanilloid  1  (TRPV1), and the orphan G -protein-coupled receptors G PR 55 and 
G PR119. N A Es participate in the regulation of m any physiological processes and they have 
neuroprotective, antinociceptive, and anti-inflam m atory effects [29] . In this paper, w e found that 
a cocaine-induced relapse resulted in a potent increase in O EA  levels in the prefrontal cortex and 
striatum  and in PEA  in  the prefrontal cortex, hippocam pus and dorsal striatum . A t the sam e tim e, 
there w ere potent reductions in the N A Es level in the rat cerebellum . The above changes w ere 
noted for chronic cocaine experienced rats, w hile a decrease in the tissue levels o f O EA  and PEA  
observed in the nucleus accum bens w as linked w ith  cocaine relapse in  rats. D ecreased levels of 
O EA  and P EA  in nucleus accum bens after the cocaine challenge only in rats self-adm inistering 
cocaine suggest an im paired control of the release of neurotransm itters during reinstatem ent, and 
correlate w ith  the previously  reported the participation of the TRPV1 receptor [13,20,28] . Recently, 
Zambrana-Infantes et al. (2018) demonstrated that repeated administration of PEA can block behavioral 
cocaine sensitization in the m echanism , probably independent of the P PA R -a receptor, bu t rather
as a result of the anti-inflam m atory properties of PEA  [29]. The decrease in PEA  and O EA  in the 
nucleus accum bens observed in our study m ay confirm  the increased cocaine sensitization as a result 
of the habit form ing, since the sam e changes have not been observed in cocaine-experienced anim als 
follow ing repeated passive (yoked) treatm ent. It is also w orth  noting that acute adm inistration of 
OEA reduced cocaine locom otion or reward but did not affect cocaine sensitization, conditioned place 
preference, and reinstatem ent to cocaine in PPA Ra receptor knockout in mice [30]. The decrease in PEA 
and O EA in nucleus accumbens observed in our study may confirm the increased cocaine sensitization 
after a cocaine-prim ing dose as a result of the habit form ing, bu t pharm acological analyses w ith  
selective ligands are required.
4. M aterials and M ethods
4.1. Anim als
M ale W istar rats (280-300  g, N  =  70) delivered by a licensed breeder (Charles River, G erm any) 
w ere housed individually in standard plastic rodent cages in a colony room  m aintained at 22 ±  2 ° C 
and at 45-65%  hum idity under a 12-h light-dark cycle (lights on at 06:00). The animals had free access 
to standard anim al food and w ater during the 7-day habituation period. We used a yoked procedure 
to assess w hether a m otivational factor w ould have an im pact. Then, the anim als w ere divided into 
four groups: active cocaine +  i.p. cocaine, yoked cocaine+ i.p. cocaine, yoked saline +  i.p. cocaine, and 
yoked saline + i.p. saline and those used in the cocaine self-adm inistration procedures w ere maintained 
on limited water during the initial training sessions (see below). All of the experim ents were conducted 
during the light phase of the light-d ark  cycle (between 8.00 a.m. and 3.00 p.m.) and the experim ents 
were carried out in accordance w ith the European Directive 2 0 1 0 /6 3 /E U  and approved by the Ethical 
C om m ittee at the Institute of Pharmacology, Polish A cadem y of Sciences, Krakow. All of the anim als 
used in the study w ere experim entally naive.
4.2. Drugs
Cocaine hydrochloride (Sigm a-Aldrich, St. Louis, M O, USA ), dissolved in sterile 0.9% N aCl and 
given iv (0.1 m L /in fu sion) or i.p. (1 m L /k g ).
4.3. Behavioral Procedures
4.3.1. Cocaine Self-A dm inistration, Extinction Training and Reinstatem ent of D rug-Seeking Behavior
A fter a w eek of habituation to the anim al facility, anim als w ere w ater-deprived for 18 h and 
subsequently trained to press the lever of standard operant conditioning chambers (Med-Associates, ST 
Albans City, VT, USA) under an increasing schedule of water reinforcem ent at a fixed ratio (FR) of 1 to 5. 
Two days following "lever-press" training under FR5 and free access to water, the rats were chronically 
im planted w ith  a silastic catheter in  the external right ju g u lar vein , as described previously  [31]. 
The catheters w ere flushed every day w ith  0.1 m L of saline solution containing heparin  (70 U /m L , 
Biochemie GmbH, Kundl, Austria) and 0.1 mL of solution of cephazolin (10 m g /m L ; Biochemie GmbH, 
Kundl, Austria).
A fter a 7-8-d ay  recovery period, all of the anim als w ere w ater deprived for 18 h  and trained to 
lever press to a FR 5 schedule of w ater reinforcem ent over a 2-h  session. Som e of the subjects (active 
cocaine groups) w ere then given access to cocaine during 2-h daily sessions perform ed 6  d ays/w eek  
(m aintenance) and from that tim e they w ere given ad libitum  water. The house light w as illuminated 
throughout each session. Each com pletion of five presses on the "a c tiv e" lever com plex (the FR5 
schedule) resulted in a 5-s infusion of cocaine (0.5 m g /k g  per 0.1 m L) and a 5-s presentation of a 
stim ulus com plex (activation of the w hite stim ulus light d irectly  above the "a c tiv e" lever and the 
tone generator, 2000 Hz; 15 dB above am bient noise levels). Follow ing each injection, there w as a 20-s 
tim e-out period during w hich  the responses w ere recorded bu t had no program m ed consequences.
Those on the "inactive" lever did not result in cocaine delivery. Acquisition of the conditioned operant 
response lasted a minimum of 10 days until the subjects m et the following criteria: active lever presses 
w ith  an average of 3 consecutive days and a standard deviation w ith in  those 3 days of <10%  of the 
average; this selected criterion w as based on our prior experim ents [32]. The anim als trained to 
self-adm inister cocaine (0.5 m g /k g /in fu sio n ) (w hich m et the acquisition criterion) w ere used in the 
extinction study and next in the reinstatem ent test. D uring extinction training, the subjects had 2-h  
daily training sessions w ith no cocaine delivery (saline was substituted for cocaine) and no presentation 
of the conditioned stim ulus. O nce they reached the extinction criteria (a m inim um  of 10 extinction 
days and w ith the responses to the active lever below  10%  of the level observed during m aintenance 
over at least 3 consecutive days), on the 10th day of extinction, the anim als w ere tested for the 
response reinstatem ent induced by a noncontingent presentation of a self-administered reinforcements 
(10 m g /k g  cocaine i.p.). D uring the reinstatem ent tests (2-h sessions), active lever presses on the FR5 
schedule resulted in intravenous in jection of saline. A ll of the anim als w ere sacrificed after a 2-h  
experim ental session.
4.3.2. Yoked Self-A dm inistration Procedure
The rats w ere tested sim ultaneously in groups of three w ith two rats serving as 'yoked ' controls 
that received an injection of saline or cocaine w hich w as not contingent on responding, and each time 
a response-contingent injection of 0.5 m g /k g  cocaine w as self-adm inistered by the paired rat. Unlike 
the self-adm inistering rats, the lever pressing by the yoked rats was recorded but had no programmed 
consequences [33]. The yoked saline +  i.p. saline, saline +  i.p. cocaine, and cocaine +  i.p. cocaine 
animals were sacrificed at the same time as the corresponding self-administered cocaine groups of rats 
after a 2-h experimental session of reinstatem ent drug seeking. The plan of the experim ent is presented 
in F ig u re 7.
4.4. Neurochem ical Analysis
4.4.1. L C M S/M S Analysis
Brain Structures Isolation and Tissue Preparation
The rats were sacrificed through decapitation. Selected brain structures (i.e., the prefrontal cortex, 
frontal cortex, hippocam pus, dorsal striatum , nucleus accum bens, and cerebellum ; Figure 8 panel A) 
w ere isolated, im m ediately  frozen on dry ice and stored at - 8 0  °C. the tissues w ere dissected  out 
according to The Rat Brain Atlas and to the chapter in N europroteom ics [34,35].
Cocaine (maintenance) or saline (extinction) infusions (/V)
4. Cocaine-induced reinstatement (10 mg/kg, i.p.)(l day)
1. Intravenous catheter implantation and recovery
2. Cocaine self-administration training (14 days)




Figure 7. Illustration of cocaine self-administration experiments.
Reagents
Standards of A EA , 2-A G , PEA , and O EA  w ere obtained from  Tocris (Bristol, U nited K ingdom ), 
A EA -d4, 2-A G -d5, PEA -d4 and O EA -d4 w ere from  C aym an C hem ical (A nn Arbor, M I, U SA ), 
acetonitrile and chloroform  were from M erck (Darmstadt, Germ any), w hile m ethanol and formic acid 
w ere from  PO C h (K atow ice, Poland). A ll the stock solutions of the standards, excluding 2-A G  and 
2-A G -d5, w ere prepared in ethanol, w hereas 2-A G  and 2-AG -d5 stock solutions w ere prepared in 
acetonitrile (concentration 1 m g /m L ). All the stock solutions were stored at - 8 0  °C. Further dilutions 
w ere prepared using acetonitrile.
Lipid Extraction from Brain Tissue
The extraction w as carried out by a m ethod of lipid com pounds' isolation developed by Folch in 
1957 w ith  our m odifications [36]. The tissues w ere hom ogenized in  an ice-cold m ixture of m ethanol 
and chloroform  (1:2, v /v ) at the proportion of 10 m g of w et tissue per 150 gL of solvent. N ext, 150 gL 
of the hom ogenate w as mixed w ith 250 gL of formic acid (pH 3.0; 0.2 M) and 1500 gL of the extraction 
m ixture (m ethanol: chloroform ; 1:2, v /v ). Then, 2 gL of an internal standard (A EA -d4, at 10 g g /m L ; 
2-AG-d5 at 100 g g /m L , and PEA -d4 , O EA -d4 at 5 g g /m L ) w ere added to each sam ple. The sam ples 
w ere afterw ards vortexed for 30 s and centrifuged at 2000 rpm  for 10 m in. The organic phases w ere 
collected and dried under a nitrogen stream  at 40 °C. The dry residue w as d issolved in 40 gL of 
acetonitrile and 10 gL of the reconstituted extract w as in jected into the L C -M S /M S  system  for a 
quantitative analysis purpose.
Chrom atographic Analysis: L C -M S/M S Conditions
The LC-M S Applied Biosystem  A PI 2000 (Perlan Technologies, Warsaw, Poland) instrum entation 
consisted of the follow ing com ponents: an A gilent series 1100 pum p (Santa C lara, CA , U SA ) in its 
gradient m ode and an autosam pler A gilent series 1100 w ith a 100 gL injection loop.
The chrom atographic separation w as perform ed in the gradient m ode w ith  a Therm o Scientific 
BDS H YPERSIL (W altham , M A, USA ) C18 colum n 100 x  3 m m  I.D., 3 gm  particle size. The advance 
colum n, w ith  a precolum n (10 x  3 m m  I.D ., 3 gm  particle size), w as m aintained at 40 °C  and the 
mobile phase flow rate was 0.3 m L /m in . The mobile phases for gradient elution consisted of A (formic 
acid (0.02 M ) in acetonitrile) and B (form ic acid (0.02 M ) in w ater). The gradient started initially at 0%  
A  over 1 m in, then increased linearly to 90%  by  2 m in, w here it stayed for the n ext 2 m in; before the 
solvent A  content decreased to 0%  over 6  m in. Finally, for the last 4  m in  of the analysis, the colum n 
w as maintained at 100% B to stabilize the baseline. The sam ple temperature w as maintained at 4 °C in 
the autosam pler prior to analysis.
Quantification of the analytes was performed using the tandem  electrospray M S in a positive mode 
(ESI). The data acquisition and processing w ere accom plished using the Applied Biosystem s Analyst 
version  1.4.2 softw are. Endocannabinoid  and N A E concentrations in the sam ples w ere calculated 
w ith the calibration curve prepared using the brain tissues sam ples collected from naive rats (rats not 
previously subjected to experim entation, w ithou t a particular experim ental situation and w ithou t a 
particular d ru g /an tig en  used before) to elim inate the m atrix effect. The brain  tissues sam ples w ere 
spiked w ith AEA, PEA, and O EA to obtain the concentration of 0.2; 2; 20; 50; 100; 200 n g /g  and w ith 
2-AG to obtain the concentration of 0.8; 2; 10; 20; 50; 100 g g /g . AEA-d4 , 2-AG-d5, PEA-d4 and OEA-d4 
were used as the internal standard. The procedure described for the sam ple preparation w as followed 
for sam ple analysis.
The endocannabinoid  levels w ere determ ined from  the calibration curve by m eans of linear 
regression applied to the response ratios (peak area for specific an a ly te /p e a k  area for the internal 
standard) as a function of the corresponding en d ocan n abin o id /N A E  concentration. To ensure the 
m ethod w as sufficiently thorough, analytical assessm ents for selectivity, linearity, precision, accuracy, 
recovery, and stability w ere perform ed [36].
4.4.2. Im m unohistochem istry
The rats w ere sacrificed im m ediately  after the experim ental session w ith  pentobarbital and 
perfused intracardially w ith a solution of 4% paraform aldehyde (Sigm a Aldrich, St. Louis, M O, USA) 
in 100 mM  phosphate buffer, pH 7.4 (PBS; 81 m M  Na2H PO 4, 19 mM  N aH 2PO4, 27 m M  KCl, 154 mM 
NaCS[; PO C H , G liw ice, Poland). The brains w ere excised and post-fixed in  the sam e fixative for 12 h. 
The tissue w as perm eatad w ith in  10% w /v sucrose (Sigm a A ldrich, St. Louis, M O , USA) for 7 days 
and removed in 30% w /v sucrose in PBS et 4 -8  °C for no less than 48 h. The brains were deeply frozen 
on dry i-e and cut into 12 gm coronal sections on a cryostat (Leica Mi-rosystemsa Nussloch) Germany) 
and w ese kept at —20— 22 °C  until procesued for im m unohistochem istry.
Figure 8 . Illustration of rat brain structures for detection of level of tadocannabinoid and NAEs 
(panel A; horizontal section) or immunostaining of cannabinoid CB1 and CB2 receptors after passive 
saline adminibtration, extinction trainint, anb salint iniection during remstatement (Yoked saline + i.p. 
saline) (panel IS; coronal sections). BLA—basolateral ante basomedial amygdala, CER—cerebellum,
FC—frontal cortex, HIP—hippocampus, LSN—lateral septal nueleus, MGP—medial globus pallid us,
NAC core—nucleus accumbens core, NAC shell—nucleus accumbens shell, PFC—prefrontal cortex,
SN—substantia nigra, STR—dorsal striatum, and VTA—ventral tegmental area. According to the Rat 
Brain Atlas [34].
Im m unohistochem istry Procedure
The rat brain  sections w ere rinsed in 100 m M  PBS bufter pH  7.5t ond bn PBS containing 0.1%  
Triton X-10d (Sigm a .Aldrich, St. "Louis, M O , U SA ), tor 30 m in at room  tem perature and O dyssey 
Blocked 11 uffer (OBB. Li-C O R  Biosciences, C am bridge, UK) for bh at room  tem perature. The tissue 
sections wore incubated overnight at 4 °C  w ith  purified prim ary antibodies in  O BB containing 0.1 % 
Tween 20: 1:200 dilution of rabbit m onoclonal anti-CB. receptor (Abcam, ab172970), and '1:12((S dilution 
of goat polyclonal anti-C B2 (Santa-Cruz, sc-10076; [37]). Follow ing four w ashes of 5 m in  each w ith 
PBS containing 0.1%  Tween 20, the tissue sections w ere incubated for 1 h at RT w ith  goat anti-rabbit 
(IRDye® 680CW, Li-CO R Biosciences, Cambridge, UK) and donkey anti-goat (IRDye® 800CW, Li-COR 
Biosciences, Cam bridge, UK) secondary antibodies at a dilution of 1:2000. Fluorescence w as detected 
using the Odyssey® Infrared Im aging System  (21 gm  resolution, 1 m m  offset w ith  h ighest quality) 
(Li-CO R, L incoln, N E, USA ). C hannel sensitivity w as optim ized for each set o f stained sections and
m aintained for that group of sam ples. The relative location of the slice and identification of brain
regions were determined by comparison to images in the Paxinos and Watson Rat Brain Atlas (2007) [7] 
(Figure 8 panel B).
4.5. D ata Analysis
A nim als that had problem s w ith  catheters during the recovery period, not perform ing the 
self-adm inistered acquisition and extinction criteria or those show ing incorrect perfusion w ere 
excluded from  the data analysis. A ll the data w ere expressed as m eans ( ±  SEM ). Behavioral data 
were analyzed by a two-way ANOVA for repeated measures and for statistical evolution of these data 
across the follow ing factors: lever ("activ e " and "in activ e") and sessions w here self-adm inistration, 
extinction training, and reinstatem ent of seeking behavior w ere used. Significant group differences 
according to an AN OVA w ere analyzed by  the post hoc N ew m an-K eu ls test. N eurochem ical data 
w ere analyzed by one-w ay AN OVA for different treatm ent groups (Yoked saline + i.p. saline, Yoked 
saline + i.p. cocaine, Yoked cocaine + i.p. cocaine, and A ctive cocaine + i.p. cocaine) and appropriate, 
post hoc com parisons w ere conducted by a D unnett's M ultiple Com parison test. A p value <  0.05 was 
considered as statistically significant.
5. Conclusions
W e found that endocannabinoids (AEA and 2-A G ) and endogenous noncannabinoid lipid 
signaling m olecules (PEA , O EA ) are engaged in the reinstatem ent of cocaine-seeking behavior in 
rats. O ur results support behavioral analyses w ith selective cannabinoid, TRPV1 or P PA R -a receptor 
ligands to control cocaine addiction. The present findings extend our previous observations that the 
endocannabinoid and NAE m olecules and CB1 receptors influence cocaine self-adm inistration.
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